-
REGULUS THERAPEUTICS INC NASDAQ:RGLS Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.
Location: 10628 Science Center Dr Ste 225, California, 92121-1124, US | Website: regulusrx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.166M
Cash
94.46M
Avg Qtr Burn
-8.195M
Short % of Float
5.90%
Insider Ownership
1.69%
Institutional Own.
95.67%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
RGLS8429 Details Autosomal Dominant Polycystic Kidney Disease, Kidney disease | Phase 1b Data readout |